{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:17:45Z","timestamp":1764688665697},"reference-count":42,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"the Australian National Health"},{"name":"Medical Research Council"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.2217\/17460913.3.1.67","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T16:17:58Z","timestamp":1201623478000},"page":"67-77","source":"Crossref","is-referenced-by-count":22,"title":["Vaccines for\n            <i>Chlamydia<\/i>\n            Infections of the Female Genital Tract"],"prefix":"10.1080","volume":"3","author":[{"given":"Louise M","family":"Hafner","sequence":"first","affiliation":[{"name":"School of Life Sciences &amp; Instiute of Health &amp; Biomedical Innovation (IHBI),Queensland,University of Technology,\r2 George Street,\rBrisbane,\rQld. 4001,\rAustralia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"McNeilly","sequence":"additional","affiliation":[{"name":"School of Biomedical &amp; Molecular Sciences,University of Surrey,\rGuildford,\rGU2 7XH,\rUK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,1,29]]},"reference":[{"key":"e_1_3_2_3_1_1","unstructured":"WHO . Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates.World Health Organization Geneva Switzerland (2001)."},{"key":"e_1_3_2_3_2_1","volume-title":"US Department of Health and Human Services, Centers for Disease Control and Prevention","author":"CDC","year":"2006","unstructured":"CDC . Sexually Transmitted Disease Surveillance 2005 Supplement, Chlamydia Prevalence Monitoring Project Annual Report 2005, Atlanta, GA, December 2006.US Department of Health and Human Services, Centers for Disease Control and Prevention (2006)."},{"key":"e_1_3_2_3_3_1","first-page":"1","article-title":"2004 Canadian Sex. Transm. Infect. Surveillance Report.","volume":"33","author":"Canada P.H.A.o.","year":"2004","unstructured":"Canada P.H.A.o. 2004 Canadian Sex. Transm. Infect. Surveillance Report. CCDR 33SI , 1\u201369 (2004).","journal-title":"CCDR"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/513844"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.1.22"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1363\/3600604"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030542"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/5.5.433"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi262"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.233"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsre.2005.03.002"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.3.1795-1799.2006"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.1999.00012.x"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.758-766.1997"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2000.00059.x"},{"key":"e_1_3_2_3_17_1","unstructured":"McNeilly C : Identification of novel antigens for the development of a vaccine to prevent sexually transmitted chlamydia infections in School of Life Sciences Institute of Health and Biomedical Innovation.PhD Thesis QUT Brisbane (2007)."},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.10.6240-6247.2001"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4812-4817.2002"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00526-5"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00088-3"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.2.1019-1028.2004"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199700541-00005"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.7.3211"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8153-8160.2005"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00175-9"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00132-4"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00117-7"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.04.035"},{"issue":"3","key":"e_1_3_2_3_30_1","first-page":"188","article-title":"Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.","volume":"40","author":"Ifere G","year":"2007","unstructured":"Ifere G , HeQ, IgietsemeJUet al.: Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.J. Microbiol. Immunol. Infect.40(3) , 188\u2013200 (2007).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.07.045"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.010"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01280-06"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.019"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603866103"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1086\/315601"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/7716"},{"key":"e_1_3_2_3_38_1","volume-title":"New Canaan","author":"Woodall JP","year":"2003","unstructured":"Woodall JP : Proceedings of the Chlamydia Vaccine Development Colloquium.New Canaan. JPWoodall (Ed.). The Albert B. Sabin Vaccine Institute, USA (2003)."},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)80022-6"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.9.4030-4035.1998"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.021"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/17460913.3.1.67","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:22Z","timestamp":1719124702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/17460913.3.1.67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,29]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.2217\/17460913.3.1.67"],"URL":"https:\/\/doi.org\/10.2217\/17460913.3.1.67","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,29]]}}}